PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, announced that the University of Wisconsin presented a new trial concept of X-82 poster at ASCO in Chicago.
Category: News
Researchers identify 763 proteins in human aqueous humor that nourish the cornea and the lens
Researchers conducting a comprehensive proteomics analysis of human aqueous humor samples identified 763 proteins – including 386 proteins detected for the first time – in this clear fluid that helps maintain pressure in the eye and nourishes the corne…
A Low-Cost Digital Ophthalmoscope for Your Smartphone [Interview]
Ophthalmoscopes aren’t the easiest things to use. Practicing for clinical exams, groups of medical students get together and when one exclaims “I SEE IT I SEE IT!”, nobody else seems to be able to verify the findings. I’m a second year medical student myself, and I think I’ve found one optic disc in an u (Read more...)
Wide Data Sharing Poses Problems With Consent
Current regulations for obtaining consent from study participants have not kept up with big data, and researchers are grappling with how to protect privacy as data get shared and uses evolve. Medscape Medical News
Peek eye testing app shown to work as well as charts for visual acuity
An app to test eyesight easily and affordably using a smartphone is as accurate as traditional charts, according to a study published yesterday.
Deciphering dark and bright
The human sensory systems contend with enormous diversity in the natural world.
Study finds Peek eye testing app as accurate as traditional charts
An app to test eyesight easily and affordably using a smartphone is as accurate as traditional charts, according to a study published today.
Metformin can reduce risk of open-angle glaucoma in people with diabetes
Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.
Dermal Fillers May Rarely Cause Serious Injury, FDA Warns
Unintentional injection of a dermal filler into blood vessels in the face may cause serious injury, the FDA warns; asks manufacturers to update labeling to indicate risk. News Alerts
Bungee Cord Trauma to the Eye
What did an elastic cord injury do to this man’s eye? Medscape Ophthalmology
Severe Vision Loss Linked to Poverty in CDC Study
The prevalence of severe vision loss was highest in the poorest counties in the South. Medscape Medical News
Research and Markets: Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/mn2tbt/keratoconjunctivit) has announced the addition of the “Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2015” report to their offering. This repo…
Aerie Pharmaceuticals to Participate in Two Investor Conferences in June
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today that Vicente Anido, Jr., Ph.D., Chief Executive Officer and Chairman of the Board, will present an overview of the company at the following conferences in
Vision Problems Rare in Children With Dyslexia
Vision-based interventions are unlikely to improve severe reading impairment. Medscape Medical News
Genetic defect linked to visual impairment in dyslexics
A risk gene for dyslexia is associated with impairments in visual motion detection, according to a study published May 27 in The Journal of Neuroscience.
Dyslexia in Kids Not Caused by Vision Problems (CME/CE)
(MedPage Today) — No association found between vision abnormalities and reading impairment.
What to Do If an Insurer Profiles You as a High Utilizer
Ophthalmologists are increasingly being told by insurers that their treatments cost more than their peers’ and are being penalized or booted out of health plans as a result. Here’s how to respond. Medscape Business of Medicine
Ocata Therapeutics Receives Three New U.S. Patents for its RPE Therapy for Macular Degenerative Diseases
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that the United States Patent and Trademark Office (USPTO) issued three new U.S. Patents, Nos. 9,040,770, 9,040,039 and 9,040,038, which expand the scope of protection of the four previously issued U.S. patents covering its retinal pigment epithelium (RPE) transplant technology. These three new patents extend protection to
Momentive to Present New Silicone Polymers for Contact Lens Industry
WATERFORD, N.Y.–(BUSINESS WIRE)–Momentive to present two technical posters highlighting the benefits of the new OphthaSil* silicone polymer product portfolio for the contact lens industry.
Study suggests new way of preventing diabetes-associated blindness
Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one…